Tailored cancer cocktail fails to advance in Kids' neuroblastoma trial
NCT ID NCT02780128
First seen Mar 11, 2026 · Last updated May 21, 2026 · Updated 14 times
Summary
This study tested a personalized approach for children with neuroblastoma that had come back or not responded to treatment. Doctors analyzed each child's tumor genes to pick a combination of targeted drugs. The goal was to control the cancer, not cure it, and the trial was stopped early after enrolling 66 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.